Nifuroxazide in combination with CpG ODN exerts greater efficacy against hepatocellular carcinoma.
Wang Y, Liu W, Liu M, Wang H, Zhou L, Chen J, Sun H, Wei X, Fan M, Yang M, Liu Z, Yang Z, Zhong J, Lu C, Zhao T, Jia H.
Wang Y, et al. Among authors: liu z, liu m, liu w.
Int Immunopharmacol. 2022 Jul;108:108911. doi: 10.1016/j.intimp.2022.108911. Epub 2022 Jun 1.
Int Immunopharmacol. 2022.
PMID: 35729838